Notes to SEFA
The accompanying schedule of expenditures of federal awards presents the activity of federal financial assistance and federal cost-reimbursement contracts of Tufts Medicine, Inc. and affiliates (the “System”). Operations related to the System’s federal grant programs are included in the scope of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. The federal oversight agency for the System is the Department of Health and Human Services (DHHS). Expenditures related to federal grant funds are recorded on the accrual basis of accounting. Program Clusters—For the year ended September 30, 2025, the following program clusters were identified: • Research and Development • Student Financial Assistance Major Programs—Major programs are identified in the summary of auditor’s results section of the schedule of findings and questioned costs.
The System has elected not to use the 15% indirect cost rate allowed under the Uniform Guidance, and instead uses the modified total direct cost basis to determine the facilities and administrative rate. The rates used during 2025 were based on approved rates as received from DHHS.
As of September 30, 2025, there were no loans outstanding to students under federal programs, as the Nursing Student Loan Program had been discontinued. Federal Family Education loans are administered by outside financial institutions, and balances and transactions relating to these programs are not included in the System’s consolidated financial statements.
During the year ended September 30, 2025, the System did not receive any donated medical equipment from a federal awarding agency.
The System applied for reimbursement of certain expenses related to the COVID-19 pandemic under Assistance Listing Number 97.036, FEMA Public Assistance through the Commonwealth of Massachusetts. Expenditures thus includes $9,533,161 of expenditures incurred in fiscal years 2022 through 2024, which were obligated in fiscal year 2025 and represents a reconciling item between the federal expenses in the System's financial statements and the amount included on the Schedule.